HR 6963 · 118th Congress · Health
Pediatric Cancer Drug Supply Act of 2024
Bill Progress
✓
Introduced2
Committee3
House Vote4
Senate5
EnactedLatest: Referred to the Subcommittee on Health.(2024-01-12)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 6963 Introduced in House (IH)] <DOC> 118th CONGRESS 2d Session H. R. 6963 To direct the Secretary of Health and Human Services to enter into agreements with drug manufacturers to establish reserve supplies of covered pediatric cancer drugs, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES January 11, 2024 Ms. Eshoo (for herself, Ms. DeGette, and Ms. Schrier) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To direct the Secretary of Health and Human Services to enter into agreements with drug manufacturers to establish reserve supplies of covered pediatric cancer drugs, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Pediatric Cancer Drug Supply Act of 2024''. SEC. 2. ESTABLISHMENT OF ESSENTIAL PEDIATRIC CANCER DRUG MARKETPLACE STABILITY PILOT PROGRAM. (…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (15)
15 Democrats